Among direct-to-consumer telehealth platforms for compounded semaglutide and tirzepatide, Amble and Gala Health both cater to self-pay patients seeking to avoid recurring $99 to $138 monthly platform subscription dues.
Both companies emphasize multi-month medication supply cycles to minimize shipping delays and keep overhead low.
However, once you examine the contractual commitment obligations, early cancellation penalties, dose-escalation pricing tiers, and pharmacy fulfillment networks, substantial differences emerge. Amble locks members into mandatory 3-month contracts with early termination penalties, whereas Gala Health offers transparent, prepaid 3-month bundles with flexible cancellation notice and zero penalty clauses.
Here is how Amble and Gala Health compare head-to-head across pricing, contractual terms, and patient flexibility in 2026.
Featured Transparent 3-Month Alternative
Gala Health All-Inclusive 3-Month GLP-1 Bundles
Avoid rigid 3-month contract lock-ins and early cancellation penalty clauses. Gala Health delivers all-inclusive 3-month packages ($597 semaglutide = $199/mo, $897 tirzepatide = $299/mo) with zero hidden fees, flat renewals across maintenance doses, and a simple 72-hour cancellation notice window.
Affiliate disclosure: Care Path Compare maintains an affiliate relationship with Gala Health. If you enroll through our links, we may receive compensation at zero extra cost to you. Commercial partnerships never influence our objective fee audits, contractual terms reviews, or clinical comparisons. Amble is evaluated independently as an industry benchmark.
1. Feature & Cost Comparison Matrix
The table below contrasts the fundamental pricing models, contract terms, and operational policies between Amble and Gala Health:
| Feature / Criteria | Amble (Amble Health LLC) | Gala Health (Gala Telehealth Inc.) |
|---|---|---|
| Monthly Membership Fee | $0 / month (No separate dues) | $0 / month (No separate dues) |
| Plan Billing Structure | Monthly billing with 3-month lock-in | All-inclusive prepaid 3-month bundles |
| Starting Semaglutide Rate | $199 / month | $597 per 3-month bundle ($199/mo equivalent) |
| Ongoing Semaglutide Renewal | $199–$229 / month (Tiered by dose) | $597 flat renewal ($199/mo across maintenance) |
| Starting Tirzepatide Rate | $299 / month | $897 per 3-month bundle ($299/mo equivalent) |
| Ongoing Tirzepatide Renewal | $299–$379+ / month (Tiered by dose) | $897 flat renewal ($299/mo across maintenance) |
| Contract Commitment Rules | Mandatory 3-month agreement | Prepaid per bundle (No multi-cycle lock-in) |
| Early Cancellation Penalties | Yes (Penalty fee or balance due) | None (72-hour notice prior to next bundle) |
| Compounding Pharmacy Network | 503A partner labs (ReviveRx, TX ProMed) | Licensed state 503A compounding pharmacy network |
| Consultation Format | Asynchronous digital intake | Asynchronous clinician intake + ongoing medical support |
| State Availability | Nationwide (All 50 U.S. States) | Nationwide (All 50 U.S. States) |
| Shipping Fees | Free expedited cold-pack shipping | Free temperature-controlled shipping |
2. Contract Lock-In vs. Prepaid Bundle Freedom
The defining difference between Amble and Gala Health is how their 3-month commitment terms are legally structured and enforced:
Amble’s 3-Month Mandatory Contract Lock-In
Amble advertises monthly billing ($199/month for semaglutide, $299/month for tirzepatide), but embeds a mandatory commitment clause in its terms of service:
- The 3-Month Requirement: When registering for an initial GLP-1 program, patients agree to a binding 3-month commitment.
- Early Termination Penalties: If a patient experiences severe nausea, vomiting, or personal financial distress and requests to terminate after Month 1 or Month 2, Amble’s policy states that the patient remains financially liable for the remaining term or subject to an early cancellation penalty fee.
- Dispensing Schedule: In many instances, medications are shipped in multi-month vials upfront, creating significant billing disputes if patients decide to pause treatment early.
Gala Health’s Transparent Prepaid Bundles
Gala Health approaches multi-month care through upfront transparency rather than long-term contract lock-ins:
- All-Inclusive Bundles: Patients pay for a 3-month package upfront ($597 for semaglutide, $897 for tirzepatide). This breaks down to exactly $199/month and $299/month.
- No Recurring Contract Dues: You are not trapped in a recurring 12-month auto-contract. If you do not wish to reorder a subsequent 3-month package, you simply submit notice 72 hours prior to your scheduled renewal date with zero penalty fees.
- Clear Budgeting: There are no surprise monthly bank drafts or early termination settlement fees.
3. Real-World 12-Month Outlay Math
Over a standard 12-month clinical weight management protocol, dose escalation and renewal fees determine total out-of-pocket costs:
12-Month Outlay Comparison (Compounded Semaglutide):
┌────────────────────────────────────────────────────────┐
│ Amble: $2,508.00 │
│ (3 mos x $199 + 9 mos escalated at $219/mo avg) │
├────────────────────────────────────────────────────────┤
│ Gala Health: $2,388.00 │
│ (4 quarterly bundles x $597 flat) │
├────────────────────────────────────────────────────────┤
│ Net Annual Savings with Gala Health: $120.00 │
└────────────────────────────────────────────────────────┘
12-Month Tirzepatide Scenario
The financial variance is significantly greater on compounded tirzepatide, where maintenance doses frequently trigger price jumps at Amble:
- Amble:
- Months 1–3 (Starter 2.5–5 mg): 3 × $299 = $897.00
- Months 4–12 (Maintenance 7.5–10 mg+ at $379/mo): 9 × $379 = $3,411.00
- Total 12-Month Cash Outlay: $4,308.00
- Gala Health:
- Package 1 (Months 1–3 Starter): $897.00
- Packages 2–4 (Months 4–12 Flat Renewal at $897/bundle): 3 × $897 = $2,691.00
- Total 12-Month Cash Outlay: $3,588.00
- Net Annual Savings with Gala Health: $720.00
4. Dose Escalation & Maintenance Surcharges
- Gala Health: Eliminates dose-escalation price shocks. Whether your clinician maintains you at starter dosing or increases you to standard clinical maintenance, your 3-month renewal rate remains fixed at $597 for semaglutide and $897 for tirzepatide. This saves tirzepatide patients over $700 per year as dosages increase.
- Amble: While starter doses are priced competitively at $199 and $299, patients who titrate to higher maintenance dosages (such as 7.5 mg, 10 mg, or higher tirzepatide) may encounter price tier adjustments, increasing monthly expenditures as treatment progresses.
5. Compounding Pharmacy Sourcing & Shipping
- Amble: Fulfills compounded GLP-1 medications through licensed state 503A compounding pharmacies, notably including ReviveRx and TX ProMed (depending on the patient’s state). Supplies include standard insulin syringes, alcohol prep pads, and cold-pack shipping.
- Gala Health: Utilizes a vetted nationwide network of licensed 503A compounding pharmacy partners operating under strict cGMP release testing. Vials arrive in insulated cold packs with explicit lot numbers, certificates of analysis, beyond-use dates (BUD), and complete subcutaneous injection gear.
The Verdict: Which Provider Should You Choose?
- Choose Amble if: You prefer monthly billing installments over paying for a 3-month bundle upfront, are 100% confident you will stay on treatment for at least 90 days without needing to cancel early, and are comfortable with potential dose-escalation tiers.
- Choose Gala Health if: You want complete freedom from early termination penalty clauses, prefer paying for 3-month supplies upfront without surprise monthly bank drafts, want flat renewals that save you $720 per year on tirzepatide, and demand flexible 72-hour cancellation terms.
Order All-Inclusive Care with Gala Health
Get 3 full months of doctor-supervised compounded semaglutide ($597) or tirzepatide ($897). No monthly dues, flat ongoing maintenance renewals, and zero early termination penalty clauses.